New Zealand Takes Bold Step in Mental Health: MDMA Approved for PTSD Treatment
By Editor • September 4, 2026 • 1 min read
In a groundbreaking decision, New Zealand's Medsafe has granted psychiatrists the authority to prescribe pharmaceutical-grade MDMA for patients suffering from severe post-traumatic stress disorder (PTSD). This move positions New Zealand as only the second country globally to endorse the use of this psychedelic substance for therapeutic purposes.
The approval comes in the wake of similar actions taken by Australia earlier this year, where the use of psychedelics was also legalized for the treatment of PTSD and treatment-resistant depression. This growing trend highlights a shift in the approach to mental health treatments, moving towards innovative solutions that were once considered controversial.
With this new regulation, psychiatrists in New Zealand can now explore the potential benefits of MDMA in therapeutic settings, aiming to provide relief for individuals grappling with the debilitating effects of PTSD.
Source: www.theguardian.com
